Sponsor:
Ottawa Heart Institute Research Corporation
Code:
NCT05298124
Conditions
Cardiogenic Shock
Mitral Regurgitation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Transcatheter edge-to-edge repair
Medical therapy
Brief summary:
Conditions
Cardiogenic Shock
Mitral Regurgitation
Study ID
NCT05298124
Start date
May 26, 2022
Status verified date
Apr, 2026
Completion date
May, 2028
Anticipated
Primary completion date
May, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
144 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Transcatheter edge-to-edge repair
active comparator: Medical therapy
Interventions
Transcatheter edge-to-edge repair
Medical therapy
Primary outcome measure
Central contacts
Locations
Mayo Clinic
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Benjamin Hibbert, MD PhD
hibbert.benjamin@mayo.eduUniversity of Ottawa Heart Institute
Recruiting
Ottawa, Ontario, Canada, K1Y4W7
Contacts
Principal Investigator:
Rebecca Mathew, MD
Sponsor
Ottawa Heart Institute Research Corporation
Last update posted
May 6, 2026
Last verified
Apr, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Ottawa Heart Institute Research Corporation on 2026-05-06.